The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACELYRIN INC | COM | 00445A100 | BBG00YJKJ8H4 | 6,497,020 | 1,317,854 | SH | SOLE | 1,121,151 | 0 | 196,703 | ||
| ALKERMES PLC | SHS | G01767105 | BBG000C9F2F9 | 1,369,215 | 48,918 | SH | SOLE | 48,918 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | BBG000PLF6N0 | 15,825,720 | 1,481,809 | SH | SOLE | 1,256,240 | 0 | 225,569 | ||
| APPLIED THERAPEUTICS INC | COM | 03828A101 | BBG000DD0489 | 13,213,981 | 1,554,586 | SH | SOLE | 1,218,119 | 0 | 336,467 | ||
| APPLIED THERAPEUTICS INC | COM | 03828A101 | BBG01LM8Q3M1 | 75,480 | 251,600 | SH | Call | SOLE | 251,600 | 0 | 0 | |
| ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4S9 | 5,016,947 | 60,076 | SH | SOLE | 60,076 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 16,538,357 | 1,778,318 | SH | SOLE | 1,528,833 | 0 | 249,485 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG01P8CNZ50 | 12,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 618,876 | 56,287 | SH | SOLE | 56,287 | 0 | 0 | ||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG00KVT05R6 | 9,498,265 | 2,616,602 | SH | SOLE | 2,025,062 | 0 | 591,540 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 10,815,507 | 216,440 | SH | SOLE | 199,961 | 0 | 16,479 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | BBG00P9KDZK6 | 2,415,772 | 94,885 | SH | SOLE | 94,885 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | BBG000DQLV23 | 14,244,177 | 275,303 | SH | SOLE | 275,303 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKW2 | 6,034,256 | 1,278,444 | SH | SOLE | 1,015,521 | 0 | 262,923 | ||
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | BBG000DZMK99 | 1,424,234 | 93,638 | SH | SOLE | 93,638 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01081FC59 | 1,337,755 | 83,662 | SH | SOLE | 83,662 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG00BC59224 | 10,925,947 | 213,815 | SH | SOLE | 199,193 | 0 | 14,622 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | BBG000F0R4N9 | 763,699 | 14,464 | SH | SOLE | 0 | 0 | 14,464 | ||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | BBG00V1KSN04 | 7,062,204 | 506,978 | SH | SOLE | 506,978 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | BBG008P7F869 | 8,216,117 | 282,050 | SH | SOLE | 244,770 | 0 | 37,280 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | BBG00K4Y2H24 | 531,131 | 19,900 | SH | SOLE | 19,900 | 0 | 0 | ||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | BBG01L3GYF02 | 2,089,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | BBG00CTZ4D83 | 4,204,031 | 132,703 | SH | SOLE | 132,703 | 0 | 0 | ||
| IMMATICS N.V | SHS | N44445109 | BBG00VTL2H76 | 5,131,476 | 449,735 | SH | SOLE | 449,735 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 19,130,239 | 671,001 | SH | SOLE | 578,259 | 0 | 92,742 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG01NQM5Z80 | 37,500 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| IMMUNOVANT INC | COM | 45258J102 | BBG01NQM49D3 | 75,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| INCYTE CORP | COM | 45337C102 | BBG000BNPSQ9 | 8,559,289 | 129,490 | SH | SOLE | 129,490 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 2,244,923 | 49,415 | SH | SOLE | 49,415 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | BBG00H1HP9G9 | 5,048,025 | 86,930 | SH | SOLE | 69,070 | 0 | 17,860 | ||
| MBX BIOSCIENCES INC | COM | 55287L101 | BBG00W7W53M5 | 1,299,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 21,044,251 | 421,222 | SH | SOLE | 373,461 | 0 | 47,761 | ||
| NEUROGENE INC | COM | 64135M105 | BBG005Y0QDK1 | 3,075,626 | 73,299 | SH | SOLE | 73,299 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | BBG00SDJ8M78 | 4,561,747 | 203,015 | SH | SOLE | 171,104 | 0 | 31,911 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | BBG01N0FG6L0 | 1,503,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | BBG000BG5HT7 | 3,178,421 | 238,084 | SH | SOLE | 238,084 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | BBG00W9LF2G5 | 10,013,916 | 174,034 | SH | SOLE | 153,467 | 0 | 20,567 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG001ZLYSH5 | 1,725,428 | 942,857 | SH | SOLE | 942,857 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | BBG00PQFFCV5 | 3,120,271 | 850,210 | SH | SOLE | 850,210 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | BBG00829F4P8 | 755,259 | 16,654 | SH | SOLE | 0 | 0 | 16,654 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 2,162,031 | 41,268 | SH | SOLE | 41,268 | 0 | 0 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 31,963,711 | 2,769,819 | SH | SOLE | 2,606,428 | 0 | 163,391 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | BBG000BCJ161 | 1,875,098 | 15,014 | SH | SOLE | 0 | 0 | 15,014 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | BBG0024L5B86 | 6,219,207 | 123,177 | SH | SOLE | 104,362 | 0 | 18,815 | ||
| SURROZEN INC | COM NEW | 86889P208 | BBG00XY94S95 | 2,191,358 | 182,918 | SH | SOLE | 138,663 | 0 | 44,255 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 33,325,427 | 1,731,191 | SH | SOLE | 1,424,829 | 0 | 306,362 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01PQ8H8M7 | 141,750 | 105,000 | SH | Call | SOLE | 105,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01LJN53G2 | 18,750 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01JN3CNZ3 | 221,250 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| TERNS PHARMACEUTICALS INC | COM | 880881107 | BBG00KK1SJ08 | 3,747,337 | 449,321 | SH | SOLE | 449,321 | 0 | 0 | ||
| TOURMALINE BIO INC | COM | 89157D105 | BBG00NX995R3 | 1,427,496 | 55,523 | SH | SOLE | 55,523 | 0 | 0 | ||
| TSCAN THERAPEUTICS INC | COM | 89854M101 | BBG00PH1N007 | 4,287,536 | 860,951 | SH | SOLE | 725,498 | 0 | 135,453 | ||
| UROGEN PHARMA LTD | COM | M96088105 | BBG00GFCC613 | 3,073,197 | 241,984 | SH | SOLE | 213,257 | 0 | 28,727 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | BBG00YGBK4Q4 | 2,528,645 | 743,719 | SH | SOLE | 642,095 | 0 | 101,624 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 1,198,136 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 3,702,429 | 1,230,043 | SH | SOLE | 975,260 | 0 | 254,783 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V54 | 2,460,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | BBG011FJXV49 | 4,239,322 | 1,044,168 | SH | SOLE | 843,363 | 0 | 200,805 | ||